Biotech Values

[DewDiligence]

Re: HOW CROWDED IS THE CANCER-DRUG ARENA?

[This excerpt from last Sunday’s NY Times makes a good companion to the WSJ article in the previous post.]

http://www.nytimes.com/2004/06/06/health/06CANC.html

>>
Surveys over the last couple of years by the Pharmaceutical Research and Manufacturers of America found 395 drugs in clinical trials for cancer, compared with 122 for heart disease and stroke combined and 176 for neurological disorders.

Another survey of only biotechnology-related drugs in clinical trials found nearly half were for cancer, far more than for any other disease.

Indeed, so many cancer drugs are in development that oncologists say it is becoming difficult to run all the clinical trials needed to test them and to determine the best sequences and combinations in which to use them. One session here is titled "Therapy for Metastatic Colorectal Cancer: What Do We Do with So Many Options?
<<